EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia



Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia



Drug Design, Development and Therapy 9: 313-320



According to the World Health Organization, 46% of the world's children suffer from anemia, which is usually treated with iron supplements such as ferrous sulfate. The aim of this study was to prepare iron as solid lipid nanoparticles, in order to find an innovative way for alleviating the disadvantages associated with commercially available tablets. These limitations include adverse effects on the digestive system resulting in constipation and blood in the stool. The second drawback is the high variability in the absorption of iron and thus in its bioavailability. Iron solid lipid nanoparticles (Fe-SLNs) were prepared by hot homogenization/ultrasonication. Solubility of ferrous sulfate in different solid lipids was measured, and effects of process variables such as the surfactant type and concentration, homogenization and ultrasonication times, and charge-inducing agent on the particle size, zeta potential, and encapsulation efficiency were determined. Furthermore, in vitro drug release and in vivo pharmacokinetics were studied in rabbits. Results indicated that Fe-SLNs consisted of 3% Compritol 888 ATO, 1% Lecithin, 3% Poloxamer 188, and 0.2% dicetylphosphate, with an average particle size of 25 nm with 92.3% entrapment efficiency. In vivo pharmacokinetic study revealed more than fourfold enhanced bioavailability. In conclusion, Fe-SLNs could be a promising carrier for iron with enhanced oral bioavailability.

(PDF emailed within 0-6 h: $19.90)

Accession: 058875892

Download citation: RISBibTeXText

PMID: 25609917

DOI: 10.2147/DDDT.S77702



Related references

Prenatal Iron Supplementation Reduces Maternal Anemia, Iron Deficiency, and Iron Deficiency Anemia in a Randomized Clinical Trial in Rural China, but Iron Deficiency Remains Widespread in Mothers and Neonates. Journal of Nutrition 145(8): 1916-1923, 2015

Reversal of iron deficiency anemia-induced peripheral neuropathy by iron treatment in children with iron deficiency anemia. Journal of Tropical Pediatrics 48(4): 204-209, 2002

Studies on the pathogenesis in iron deficiency anemia part 1. urinary iron excretion in iron deficiency anemia patients and rats in various iron states. Okayama Igakkai Zasshi 103(7-8): 803-812, 1991

Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. Expert Opinion on PharmacoTherapy 15(14): 2087-2103, 2014

Time course of changes in clinical and hematological parameters, iron metabolism, and free radical lipid oxidation in patients with iron-deficiency anemia during multimodality treatment. Klinicheskaia Laboratornaia Diagnostika: 41-43, 2007

In vitro and in vivo study of solid lipid nanoparticles loaded with superparamagnetic iron oxide. Journal of Drug Targeting 11(1): 19-24, 2003

A novel approach to oral iron delivery using ferrous sulphate loaded solid lipid nanoparticles. International Journal of Pharmaceutics 456(2): 400-407, 2014

Iron-dextran. Total dose infusion in the treatment of iron deficiency anemia. MEHTA, B. C., AMBANI, L. M., PAWASKAR, M. and PATEL, J. C. Total dose injection (I.V. undiluted) in the treatment of iron deficiency anemia. Indian J. Med. Sci, 22: 1, 1968

Plasma ferritin and soluble transferrin receptor concentrations and body iron stores identify similar risk factors for iron deficiency but result in different estimates of the national prevalence of iron deficiency and iron-deficiency anemia among women and children in Cameroon. Journal of Nutrition 143(3): 369-377, 2013

Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report. Turkish Journal of Gastroenterology 28(2): 81-87, 2017

Diagnosis and treatment of iron deficiency anemia during pregnancy and the postpartum period: Iron deficiency anemia working group consensus report. Turkish Journal of Obstetrics and Gynecology 12(3): 173-181, 2015

Iron fortification of whole wheat flour reduces iron deficiency and iron deficiency anemia and increases body iron stores in Indian school-aged children. Journal of Nutrition 142(11): 1997-2003, 2013

Studies on iron metabolism and iron deficiency anemia in pregnant women theoretical discussion on the relation between serum iron level and iron dose clinical results after iron therapy. Acta Obstetrica et Gynaecologica Japonica (Japanese Edition) 32(7): 833-841, 1980

Studies on iron metabolism and iron deficiency anemia in pregnant women--theoretical discussion on the relation between serum iron level and iron dose to be administrate, and clinical result after iron therapy. Nihon Sanka Fujinka Gakkai Zasshi 32(7): 833-841, 1980

Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure. Journal of the American College of Cardiology 60(21): 2255-2256, 2013